Cannabis Advertising Restrictions in Spain
Spain bans most cannabis advertising under drug, health, and audiovisual laws — even for legal hemp and CBD products in many contexts.
Spain has a reputation as cannabis-friendly because of its private clubs and decriminalised personal use, but that tolerance does not extend to advertising. Promoting cannabis — including most CBD products marketed for human consumption — is broadly restricted under drug, consumer, audiovisual, and health legislation. Penalties are administrative, not just theoretical. If you are running a brand, a club, or a shop in Spain, assume advertising is prohibited unless a lawyer tells you otherwise in writing.
Legal status of cannabis in Spain (context)
Spain decriminalises personal possession and consumption of cannabis in private but criminalises cultivation, trafficking, and any consumption or possession in public spaces. The framework comes from the Penal Code (arts. 368–378) and from Ley Orgánica 4/2015 on the protection of public safety, which sets administrative fines for public use and possession [1] Strong evidence. Cannabis social clubs operate in a legal grey zone built on jurisprudence rather than statute; the Supreme Court has repeatedly held that organised collective cultivation is not protected by the right of personal consumption (e.g. STS 484/2015) [2] Strong evidence.
Because cannabis with psychoactive THC content remains a controlled substance, it inherits the strictest tier of advertising restrictions under Spanish and EU law.
What statutes actually restrict cannabis advertising
Several overlapping laws make cannabis advertising effectively impossible in Spain:
- Ley 17/2011 on food safety and nutrition (art. 44) prohibits the advertising of products or activities whose sale, supply or consumption is prohibited or restricted by reason of their being dangerous to health [3] Strong evidence. Spanish health authorities apply this to cannabis.
- Ley 34/1988, General de Publicidad (art. 3) declares unlawful any advertising that infringes the dignity of persons or that promotes products legally banned [4] Strong evidence. Advertising of narcotic and psychotropic substances falls within that prohibition.
- Ley 7/2010, General de la Comunicación Audiovisual (now substantially replaced by Ley 13/2022) prohibits audiovisual commercial communications for narcotic substances [5] Strong evidence. The 2022 law preserves this prohibition and adds requirements on platforms and video-sharing services [6] Strong evidence.
- Royal Decree 1907/1996 restricts advertising of products, activities or services with health-related claims, requiring prior authorisation for many therapeutic claims and banning claims of medicinal properties for unauthorised products [7] Strong evidence.
- Ley 17/1967 on narcotics still governs licit handling of controlled substances and reserves medical cannabis to authorised channels Strong evidence.
The practical result: a brand cannot legally advertise THC cannabis products, cannot make medical claims about CBD, and cannot promote a cannabis club to the general public.
CBD and hemp products
CBD sits in a separate but equally restrictive bucket. The Spanish Agency for Medicines (AEMPS) treats CBD as a substance that, when sold with therapeutic claims, becomes an unauthorised medicine [8] Strong evidence. The Spanish Food Safety Agency (AESAN) follows the European Commission position that cannabinoid extracts are novel foods under Regulation (EU) 2015/2283 and cannot be marketed for human consumption without prior authorisation [9] Strong evidence.
That means in Spain:
- Ingestible CBD (oils, edibles, capsules) marketed for human consumption is not lawfully on sale, and therefore cannot be lawfully advertised.
- Cosmetic CBD products are lawful if they comply with Regulation (EC) 1223/2009 and the CosIng database, and they can be advertised as cosmetics — but not with medicinal claims Strong evidence.
- Industrial hemp seed and fibre products are lawful; advertising them as such is permitted, but advertising them in ways that suggest psychoactive use is not.
Several Spanish CBD retailers have been sanctioned or had products seized for crossing into therapeutic claims or ingestible formats [10] Weak / limited.
Cannabis social clubs and advertising
Cannabis Social Clubs (Asociaciones Cannábicas) are private associations registered under the right of association (Ley Orgánica 1/2002). They are tolerated when they meet narrow criteria established by case law: closed membership, no profit motive, no promotion to non-members, no facilitation of consumption outside the premises [2] Strong evidence.
Any public advertising of a club — billboards, social media campaigns to the general public, flyers in the street, online listings aimed at recruiting members — risks both administrative sanctions under Ley Orgánica 4/2015 and criminal exposure under art. 368 of the Penal Code for promoting drug consumption. Catalan and Basque regional regulations attempted to formalise clubs (Ley 13/2017 in Catalonia; the Navarra law of 2014) but the Constitutional Court struck down the substantive parts in STC 144/2017 and STC 29/2018, leaving clubs without a clear legal basis to advertise [11] Strong evidence.
Penalties and enforcement
Sanctions vary by which statute is invoked:
- Ley 17/2011 classifies illegal health-related advertising as a serious or very serious infraction with fines up to €600,000 [3] Strong evidence.
- Ley 34/1988 allows cessation orders and damages actions against unlawful advertising.
- Ley 13/2022 (audiovisual) provides for fines up to €1.5 million for very serious infractions, including advertising prohibited substances [6] Strong evidence.
- Penal Code art. 368 criminalises promotion or facilitation of drug consumption, with prison sentences depending on whether the substance causes serious harm to health (cannabis is categorised as a substance that does not cause serious harm, with lighter penalties) Strong evidence.
Enforcement is uneven. In practice, large-scale or repeated advertising — especially online or in public — draws inspections and product seizures more often than fines against individuals. Local authorities and autonomous health departments handle most of the day-to-day enforcement.
What this means in practice
If you operate in or sell into Spain:
- Do not advertise THC cannabis to the general public in any medium.
- Do not market CBD for ingestion or with therapeutic claims.
- Do not promote a cannabis club to non-members; member-only communications inside a registered association are a different legal question and require local counsel.
- Cosmetic CBD and industrial hemp products can be advertised within the limits of cosmetic and food-labelling law, without psychoactive or medicinal framing.
- Platform policies (Meta, Google, TikTok) layer on top of Spanish law and are generally stricter, not looser.
This is not legal advice. Spanish cannabis regulation is fragmented across national statutes, autonomous community rules, and evolving case law. Anyone planning commercial activity should consult a Spanish lawyer. Information last verified June 2024; medical cannabis regulation in particular has been in active development since AEMPS published its draft framework in late 2023 [12] Strong evidence.
Sources
- Government Ley Orgánica 4/2015, de 30 de marzo, de protección de la seguridad ciudadana. BOE-A-2015-3442.
- Government Tribunal Supremo, Sala de lo Penal. Sentencia 484/2015, de 7 de septiembre.
- Government Ley 17/2011, de 5 de julio, de seguridad alimentaria y nutrición. BOE-A-2011-11604.
- Government Ley 34/1988, de 11 de noviembre, General de Publicidad. BOE-A-1988-26156.
- Government Ley 7/2010, de 31 de marzo, General de la Comunicación Audiovisual. BOE-A-2010-5292.
- Government Ley 13/2022, de 7 de julio, General de Comunicación Audiovisual. BOE-A-2022-11311.
- Government Real Decreto 1907/1996, de 2 de agosto, sobre publicidad y promoción comercial de productos, actividades o servicios con pretendida finalidad sanitaria.
- Government Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). Nota informativa sobre productos a base de cannabidiol (CBD).
- Government European Commission. Novel Food Catalogue entry on Cannabis sativa L. and cannabinoids.
- Reported El País. "Sanidad ordena retirar productos con CBD comercializados como complementos alimenticios." 2021.
- Government Tribunal Constitucional. Sentencia 144/2017, de 14 de diciembre, sobre la Ley 13/2017 del Parlamento de Cataluña.
- Government AEMPS. Propuesta de regulación del uso medicinal del cannabis, 2023.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.